-
1 Comment
D. Western Therapeutics Institute, Inc is currently in a long term downtrend where the price is trading 6.3% below its 200 day moving average.
From a valuation standpoint, the stock is 98.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 23.9.
D. Western Therapeutics Institute, Inc's total revenue sank by 10.6% to $115M since the same quarter in the previous year.
Its net income has dropped by 1044.3% to $-125M since the same quarter in the previous year.
Based on the above factors, D. Western Therapeutics Institute, Inc gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| ISIN | JP3548740004 |
| CurrencyCode | EUR |
| Exchange | F |
| Industry | Biotechnology |
| Dividend Yield | 0.0% |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Market Cap | 46M |
| Beta | 0.48 |
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on developing drugs to serve patients worldwide. The company offers GLANATEC, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM staining and peeling. It is also developing H-1337, a multikinase inhibitor that has completed Phase I/IIa clinical trials for the treatment of glaucoma/ocular hypertension; K-134, an antiplatelet agent, which has completed Phase IIb trials to treat arteriosclerosis obliterans; DW-1001, an ophthalmic treatment agent in nonclinical studies; and DW-5LBT, a lidocaine patch for neuropathic pain after shingles. The company was founded in 1999 and is headquartered in Nagoya, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6DW.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
